Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Connect Biopharma Initiates Phase 2 Seabreeze STAT Asthma Study Evaluating Rademikibart For Acute Exacerbations In Asthma

Author: Benzinga Newsdesk | May 13, 2025 09:01am

– Expect to report topline data from the Seabreeze STAT Asthma study in 1H 2026 –

– On track to initiate similarly-designed Phase 2 study in patients with COPD imminently –

Posted In: CNTB